News Conference News ACC 2016 Hints of What’s to Come in New Coronary Revascularization AUC Caitlin E. Cox April 12, 2016
News Conference News ACC 2016 CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men Caitlin E. Cox April 08, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why Yael L. Maxwell April 06, 2016
News Conference News ACC 2016 STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns Todd Neale April 04, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Conference News ACC 2016 Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money Caitlin E. Cox April 04, 2016
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices L.A. McKeown April 03, 2016
News Conference News ACC 2016 Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience Todd Neale April 03, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
Presentation ACC 2016 Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial Presenter: Gregg W. Stone April 03, 2016
Presentation ACC 2016 Optimal Loading Dose and Delivery of P2Y12 Inhibitors: Should the Loading Dose Be Crushed? Presenter: Dominick Angiolillo April 03, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Conference News ACC 2015 DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI Yael L. Maxwell March 17, 2015